Located in San Diego, Cardium Therapeutics is a medical technology company that develops, manufactures and sells products for cardiovascular, ischemic and related indications in the United States. The company offers various DNA-based therapeutic products, including Generx, which is a nonsurgical angiogenic therapy for patients with recurrent angina due to coronary disease. It also offers a preclinical product, Corgentin, which is designed as a one-time cardiomyocyte-directed treatment to promote the repair and restoration of damaged cardiomyocytes and enhance cardiac function following a heart attack. In addition, the company also offers a preclinical, DNA-based, endothelial nitric oxide synthase therapeutic product, Genvascor, which is used for the treatment of patients with critical limb ischemia due to advanced peripheral arterial occlusive disease.
Partial Data by Infogroup (c) 2024. All rights reserved.